Sabra Health Care REIT, Inc. (SBRA) Balance Sheet

The relatively flat asset base alongside modest debt fluctuation suggests the company has not pursued a large acquisition wave in this period. Growth in the equity line from $2.7B to $2.8B appears driven more by retained earnings than by external capital, which may indicate a balance sheet managed for stability. Investors should monitor whether future capital deployment reflects a shift in this pattern.

Because net PPE is unavailable for nine of ten quarters, the carrying value trajectory of the real estate portfolio cannot be reliably traced. The single reported figure is consistent with total assets, but it does not allow inference about occupancy, asset age, or capex-driven value changes. Verification against the underlying property schedules in SEC filings is warranted before drawing portfolio quality conclusions.

A ratio near 0.9 to 1.0 suggests the company is financed roughly evenly between debt and equity on a book basis, which is more leveraged than CTRE at 0.22 but comparable to OHI at 0.78 and NHI at 0.76. The discrepancy with the 0.90% figure cited elsewhere suggests a percentage-versus-ratio presentation issue rather than a true deleveraging event. Debt maturity structure and floating-rate exposure are not disclosed in the supplied data and warrant further investigation.

A cash balance smaller than one quarter's distributions implies reliance on operating cash flow, revolver availability, or capital markets access to sustain payouts. The supplied data does not disclose revolver capacity or covenant headroom, so the true liquidity position cannot be fully assessed. This constraint may limit flexibility to fund development or acquisitions without incremental external financing.